<!DOCTYPE html>

<html lang="en">
    <head>
        <title>Human Practices</title>
    </head>
    <body>
        <script src="./scripts/wiki.js"></script>
        <!-- <script src="/Template:Ionis_Paris/scripts/wiki?action=raw&ctype=text/javascript"></script> -->

        <div class="navigation"></div>
        <div class="tailwind"></div>
        <div id="description" x-data="{}" :style="'background-image: url(' + window.LINKS.descriptionLogo.url + ')'">
            <div class="container">
                <h1>Human Practices - IGEM IONIS</h1>
                <div class="descriptionContent">
                    <div class="descriptionText">
                        <div class="descriptionText1">Human Practices</div>
                    </div>
                </div>
            </div>
        </div>
        <div class="seeMore" target-id="overview"></div>
        <div class="mt-16" id="overview">
            <div class="container">
                <div class="punchline triggerMiddle fromBottom">
                    Antibiotic resistance<br />
                    A problem that affects the entire society
                </div>
                <h2 class="mt-8">Overview</h2>
                <div></div>
                <div class="arrowRightPrevious mt-8">From previous success...<i data-feather="arrow-right"></i></div>
                <div class="textContent mt-8 addPadding">
                    <p>
                        Antibiotics are one of the most important scientific progresses in Human History. They allowed
                        to significantly increase Human lifespan<sup>1</sup> and health comfort. This powerful solution
                        against pathogenic bacteria, discovered in 1928 by Professor Alexander Fleming helped save
                        thousands of lives and is still curing people now. Numerous families of antibiotics have been
                        discovered and the global market of antibiotics is highly valued at around USD 42,653.89 million
                        in 2018<sup>2</sup>.
                    </p>
                </div>
            </div>
            <div class="emphaseContent mt-16">
                <div class="container">
                    <div class="textContent addPadding">
                        <p>
                            Unfortunately, as the living constantly adapts to its environment, so do certain bacteria
                            who encounter antibiotics.<br />
                            <b>Antimicrobial resistance (AMR) is now one of the top priorities for Humanity health.</b>
                        </p>
                    </div>
                </div>
            </div>
            <div class="container mt-16">
                <div class="addPadding timelineMult">
                    <div class="timelineMultItem">
                        <div class="timelineMultItemTag">Today</div>
                        <div class="timelineMultItemText"><b>700 000</b> deaths/year<sup>4</sup></div>
                    </div>
                    <div class="timelineMultItem timelineMultItemMiddle">
                        <i class="timelineMultItemArrow" data-feather="arrow-right"></i>
                        <div class="timelineMultItemMult">x14</div>
                    </div>
                    <div class="timelineMultItem">
                        <div class="timelineMultItemTag">2050</div>
                        <div class="timelineMultItemText"><b>10 Million</b> deaths/year<sup>3</sup></div>
                    </div>
                </div>
                <div class="addPadding textContent mt-16">
                    <p>
                        Nowadays, this resistance is already causing a lot of harm to society. In 2011, the
                        <b>excess healthcare costs</b> of resistant bacterial infections in the US/EU was estimated at
                        $20 / 1.9€ billion<sup>5</sup>. In a report published by the Centers for Disease Control and
                        Prevention (CDC) in 2019, more than <b>2.8 million antibiotic-resistant infections</b> occur in
                        the U.S. each year, and as a result, more than 35,000 people have died<sup>6</sup>.
                    </p>
                </div>
                <div class="arrowRightNextContainer">
                    <div class="arrowRightNext mt-8">
                        <i data-feather="arrow-left"></i>to current and future ineffectiveness
                    </div>
                </div>
                <div class="mt-16 textContent addPadding">
                    <p>
                        These resistances to antibiotics are now more or less well understood. Processes like the
                        reduction of intracellular antibiotic concentrations, antibiotic inactivation or target site
                        inactivation due to pressure selection, <b>endanger a great amount of people</b>. Still, even
                        with a lot of effort to search for alternatives to antibiotics, no solution has appeared to be
                        efficient enough.
                    </p>
                </div>
            </div>
            <div class="emphaseContent mt-16">
                <div class="container">
                    <div class="textContent addPadding">
                        It is in this context that the <b>BacTail</b> project emerged. This project aims at providing
                        <b>an innovative, last resort solution</b> for AMR. Creating and using therapeutic bacteria may
                        be a powerful solution, but as AMR is a worldwide healthcare issue and affects society,
                        <b>the potential impact it could have must be discussed.</b>
                    </div>
                </div>
            </div>
        </div>
        <div id="integrated_human_practices" class="mt-16">
            <div class="container">
                <h2>Integrated Human Practices</h2>
                <div class="withPadding">
                    <i data-feather="users" class="iconBig mt-16"></i>
                    <div class="textContent mt-8">
                        BacTail, aims at bringing <b>a last resort solution to antimicrobial resistance</b> (AMR). This
                        issue is complex both for our team, who works the project’s conception, as well as for people
                        who are not familiar with AMR. Our aim was to <b>speak with key stakeholders</b> in order to get
                        their insight on different aspects of our project.
                    </div>
                </div>
                <div class="punchline mt-16">
                    Discuss with different stakeholders to shape and adapt our project<br />
                    Increased innovation, safety, reliability
                </div>
                <div class="notice text-center mt-6">(click on each icon to learn more!)</div>

                <div class="listClic mt-16" x-data="{}">
                    <div class="listClicItem" target-id="government">
                        <div class="listClicItemLeft">
                            <div class="listClicItemLeftContainer">
                                <div class="listClicItemLeftIcon"><img :src="window.LINKS.humanPratices1.url" /></div>
                                <div class="listClicItemLeftText">
                                    Government<br />
                                    Agency
                                </div>
                            </div>
                        </div>
                        <div class="listClicItemRight">In charge of studying the benefit to risk ratio of drugs</div>
                    </div>
                    <div class="listClicItem" target-id="practitioners">
                        <div class="listClicItemLeft">
                            <div class="listClicItemLeftContainer">
                                <div class="listClicItemLeftIcon"><img :src="window.LINKS.humanPratices5.url" /></div>
                                <div class="listClicItemLeftText">Practitioners</div>
                            </div>
                        </div>
                        <div class="listClicItemRight">On the field, directly facing AMR with patients</div>
                    </div>
                    <div class="listClicItem" target-id="scientists">
                        <div class="listClicItemLeft">
                            <div class="listClicItemLeftContainer">
                                <div class="listClicItemLeftIcon"><img :src="window.LINKS.humanPratices3.url" /></div>
                                <div class="listClicItemLeftText">Scientists</div>
                            </div>
                        </div>
                        <div class="listClicItemRight">In the lab, trying to understand AMR and find solutions</div>
                    </div>
                    <div class="listClicItem">
                        <div class="listClicItemLeft" target-id="veterinarians">
                            <div class="listClicItemLeftContainer">
                                <div class="listClicItemLeftIcon"><img :src="window.LINKS.humanPratices4.url" /></div>
                                <div class="listClicItemLeftText">
                                    Farmers<br />
                                    Veterinarians
                                </div>
                            </div>
                        </div>
                        <div class="listClicItemRight">On the field, facing AMR with animals</div>
                    </div>
                    <div class="listClicItem" target-id="society">
                        <div class="listClicItemLeft">
                            <div class="listClicItemLeftContainer">
                                <div class="listClicItemLeftIcon"><img :src="window.LINKS.humanPratices6.url" /></div>
                                <div class="listClicItemLeftText">Society</div>
                            </div>
                        </div>
                        <div class="listClicItemRight">
                            The first who are affected by AMR and the end users of our product
                        </div>
                    </div>
                    <div class="listClicItem" target-id="philosophy">
                        <div class="listClicItemLeft">
                            <div class="listClicItemLeftContainer">
                                <div class="listClicItemLeftIcon"><img :src="window.LINKS.humanPratices2.url" /></div>
                                <div class="listClicItemLeftText">Philosophers</div>
                            </div>
                        </div>
                        <div class="listClicItemRight">On the field, facing AMR with animals</div>
                    </div>
                </div>
            </div>
        </div>

        <!-- PAGE ELEMENT -->

        <div id="practitioners" class="mt-32">
            <div class="fixedIcon">
                <div class="fixedIconContent">
                    <img x-data="{}" :src="window.LINKS.humanPratices5.url" />
                    <div>Practitioners</div>
                </div>
            </div>
            <div class="container">
                <div class="textContent bigText addPadding">
                    It was essential for us to get the insight of practitioners because of they are on the field, facing
                    the antimicrobial issue on the field.<br />
                    The emergency point of view they had made us think about the perspectives of BacTail.
                </div>
                <div class="profile mt-16">
                    <div class="profileLine"></div>
                    <div class="profileLeft">
                        <div class="profileImg">
                            <img x-data="{}" :src="window.LINKS.humanPratices7.url" />
                        </div>
                        <div class="profileName">Dr. Blanc-Gruyelle</div>
                        <div class="profileStatus">MÉDIPÔLE HOSPITAL</div>
                    </div>
                    <div class="profileRight">
                        <div class="profileQuote">
                            "Your technology needs to be fast to produce in order to act on sepsis"
                        </div>
                        <div class="profileDescription">
                            Dr. Blanc-Gruyelle is an infectious disease specialist at the Médipôle hospital in Lyon,
                            France. We contacted her because she has a great experience in emergency cases caused by
                            AMR.
                        </div>
                    </div>
                </div>
            </div>
            <div class="mt-16 emphaseContent">
                <div class="container">
                    <div class="addPadding">
                        Dr. Blanc–Gruyelle seemed enthusiastic about our approach and convinced about our product’s
                        potential action on local infectious.
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="subProfile mt-8">
                    <i class="subProfileIcon" data-feather="navigation"></i>
                    <div>Dr. Blanc-Gruyelle brought up some issues concerning AMR and drug delivery</div>
                </div>

                <div class="issuesList mt-16">
                    <div class="issueSection">
                        <div class="issue">
                            <h3>Certain human organs cannot be easily accessed by surgery.</h3>
                            <div class="textContent">
                                <p>
                                    For example, we cannot administer liquid into the lungs. So, Dr. Blanc-Gruyelle made
                                    us think about our delivery systems for that kind of inaccessible organ. As
                                    perspectives, we could investigate nano-biotechnologies for our drug delivery
                                    system.
                                </p>
                            </div>
                        </div>
                        <div class="resolve">
                            <i data-feather="users" class="resolveIcon"></i>
                            <div class="resolveAllContent">
                                <h3>Bacteria and nanotechnology perspectives?</h3>
                                <div class="textContent">
                                    <p>
                                        After further literature, we learnt that bacteria could be used as nanomaterial
                                        producing organisms<sup>7</sup>.
                                    </p>
                                    <p>
                                        <b
                                            >A perspective of BacTail would be to use nanotechnology combined to the
                                            specific receptor binding protein of the identified bacteriophage, to
                                            precisely and locally target the pathogenic bacterium.</b
                                        >
                                        However, for the first steps of our project in the context of the iGEM
                                        competition, we decided to focus on another type of delivery method
                                        (probiotics).
                                    </p>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueSection mt-8">
                        <div class="issue">
                            <h3>Sepsis kills in 48 hours. Our system must act quickly.</h3>
                            <div class="textContent">
                                <p>
                                    Even if our software would provide a fast way to know which therapeutic bacteria to
                                    use, we also need to think about their production. Not every hospital has the
                                    technologies to produce modified bacteria so, in parallel to our proof of concept,
                                    we should work on a service to allow the hospitals to produce bacteria in a fast and
                                    safe way.
                                </p>
                            </div>
                        </div>
                        <div class="resolve">
                            <i data-feather="users" class="resolveIcon"></i>
                            <div class="resolveAllContent">
                                <h3>How would our project be implemented in the real world?</h3>
                                <div class="textContent">
                                    <p>
                                        This discussion helped us target the end users of our product as well as the
                                        scale at which it would be produced. We believe our system would first, be
                                        implemented at a small scale. Dr. Blanc-Gruyelle brought up an important factor:
                                        urgency.
                                    </p>
                                    <p>
                                        <b
                                            >We should investigate hospitals as an ideal place to implement the
                                            production of the therapeutic bacteria.</b
                                        >
                                        This will limit the time of transportation and allow to have the diagnosis and
                                        therapeutic steps at the same location.
                                    </p>
                                </div>
                                <!-- TODO : LINK TO IMPLEMENTATION -->
                                <a class="buttonLink" href="#">Check implementation</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- END PAGE ELEMENT -->

        <div id="scientists" class="mt-32">
            <div class="fixedIcon">
                <div class="fixedIconContent">
                    <img x-data="{}" :src="window.LINKS.humanPratices3.url" />
                    <div>Scientists</div>
                </div>
            </div>
            <div class="container">
                <div class="textContent bigText addPadding">
                    Scientists are in the lab trying to understand, study and find ways to fight against AMR.<br />
                    We contacted them to get expert knowledge in order to improve our project’s scientific reliability.
                </div>
                <div class="profile mt-16">
                    <div class="profileLine"></div>
                    <div class="profileLeft">
                        <div class="profileImg">
                            <img x-data="{}" :src="window.LINKS.humanPratices8.url" />
                        </div>
                        <div class="profileName">Dr. Gicquel</div>
                        <div class="profileStatus">CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION</div>
                    </div>
                    <div class="profileRight">
                        <div class="profileQuote">"Using therapeutic bacteria and not phages is a plus"</div>
                        <div class="profileDescription">
                            Dr. Gicquel is Co-director of the San Ming Tuberculosis Project at the CCDC (Chinese Center
                            for Disease Control and Prevention) of Nanshan Shenzhen China and Honorary Professor at the
                            Pasteur Institute.<br />
                            For 24 years, Dr. Gicquel created and Managed the Mycobacterial Genetics Unit at the Pasteur
                            Institute in Paris. She earned numerous rewards like the title of “Légion d’Honneur”,
                            France's highest order for her work and great contribution to Science.
                        </div>
                    </div>
                </div>
            </div>
            <div class="mt-16 emphaseContent">
                <div class="container">
                    <div class="addPadding">
                        Dr. Gicquel really enjoyed our concept and seems impressed by our strong scientific background.
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="issuesList mt-16">
                    <div class="issueCategory isStrategy">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="crosshair" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Strategy</div>
                            </div>
                            <div class="mb-6">
                                From one idea to another: signal transduction and autolysins to antimicrobial peptides
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Dr. Gicquel really made us rethink our project about our target bacteria
                                            destruction system. Up until the month of July, we were thinking about using
                                            direct signal transduction once the bacterium binds to its target which
                                            could lead to the synthesis of autolysins (like CwlC and CwlHb for example),
                                            to provoke the death of the target bacteria. After discussing the different
                                            target destruction possibilities with Dr. Gicquel, we concluded that
                                            antimicrobial peptides seemed to be most efficient option, if correctly
                                            chosen.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>How to kill the target ?</h3>
                                        <div class="textContent">
                                            <p>
                                                After further literature, we learnt that bacteria could be used as
                                                nanomaterial producing organisms<sup>7</sup>.
                                            </p>
                                            <p>
                                                The destruction of our bacterial target corresponds to phase 2 of our
                                                project. By considering Dr. Gicquel’s advice on the use of antimicrobial
                                                peptides, we redesigned phase 2, thoroughly searched for the
                                                <b
                                                    >ideal type of peptide and decided to focus on microcin PDI for our
                                                    proof of concept.</b
                                                >
                                            </p>
                                            <a x-data="{}" class="buttonLink" :href="window.ROOT_URL + '/Phases/phase2'"
                                                >Check phase 2</a
                                            >
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isSafety">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="life-buoy" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Safety</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Using therapeutic bacteria is also a strong advantage because thanks to
                                            synthetic biology, they are definitively more controllable than phages. When
                                            phages infect and kill bacteria by a lytic process, numerous phages are
                                            released which causes an environmental dispersion problem. There are ways to
                                            control the life-cycle of bacteria, which we will further discuss).
                                        </p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isPerspectives">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="rotate-ccw" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Perspectives</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            According to Dr. Gicquel, it seems totally conceivable to administer living
                                            bacteria to humans by correctly studying pharmacokinetics. It seems even
                                            more possible by administration via the intestinal mucous membranes.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>Galenic Form</h3>
                                        <div class="textContent">
                                            <p>
                                                After talking with Dr Gicquel, we took another look at our project and
                                                decided that it would be
                                                <b>ideal to deliver our bacteria under the form of probiotics.</b>
                                            </p>
                                            <p>
                                                Social understanding and acceptance regarding probiotics are a
                                                beneficial for our project.
                                            </p>
                                            <p>
                                                <b
                                                    >We decided to add an additional phase to our project uniquely
                                                    dedicated to the galenic form of our therapeutic bacteria.</b
                                                >
                                            </p>
                                            <a x-data="{}" class="buttonLink" :href="window.ROOT_URL + '/Phases/phase4'"
                                                >Check phase 4</a
                                            >
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="profile mt-16">
                    <div class="profileLine"></div>
                    <div class="profileLeft">
                        <div class="profileImg">
                            <img x-data="{}" :src="window.LINKS.humanPratices9.url" />
                        </div>
                        <div class="profileName">Dr. Debarbieux</div>
                        <div class="profileStatus">PASTEUR INSTITUTE</div>
                    </div>
                    <div class="profileRight">
                        <div class="profileQuote">
                            "The innovative side of BacTail is that the system acts locally and in a specific manner"
                        </div>
                        <div class="profileDescription">
                            Dr. Laurent Debarbieux is the Head of the “Bacteriophage, Bacterium and Host” structure at
                            the Pasteur Institute.<br />
                            Dr. Debarbieux is a specialist of phage therapy and studied the virulence of different
                            phages against certain antibiotic-resistant bacteria.
                        </div>
                    </div>
                </div>
            </div>
            <div class="mt-16 emphaseContent">
                <div class="container">
                    <div class="addPadding">
                        Dr. Debarbieux was interested by the two-step process: local targeting followed by killing.
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="issuesList mt-16">
                    <div class="issueCategory isStrategy">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="crosshair" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Strategy</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            The innovative idea is to act locally and to kill the target bacteria thanks
                                            to a concentration effect of antimicrobial peptides.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>How to kill the target ? BioBrick Designing</h3>
                                        <div class="textContent">
                                            <p>
                                                During this part of the discussion, Dr. Debarbieux pointed out an
                                                <b
                                                    >interesting relationship between the activity and the concentration
                                                    of antimicrobial peptides.</b
                                                >
                                            </p>
                                            <p>
                                                When designing our BioBrick for phase 2 we remembered that the
                                                concentration effect was important and talked about this with Dr. Call
                                                (Regents Professor of Molecular Epidemiology, Associate Director for
                                                Research and Graduate Education, Allen School), who had previously
                                                published a few articles the peptide we had decided on.
                                            </p>
                                            <a x-data="{}" class="buttonLink" :href="window.ROOT_URL + '/Phases/phase2'"
                                                >Check phase 2</a
                                            >
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isSoftware">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="hard-drive" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Software</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Dr. Debarbieux confirmed that our need of creating a software was justified.
                                            A phage only recognizes one specific spectrum of bacterial strains. If we
                                            want to treat an entire bacterial species like Salmonella, we will for sure
                                            need more than one therapeutic bacterium. Our software would be helpful
                                            generate numerous specific therapeutic bacteria.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>A software tool to help design the BioBrick for phase 1</h3>
                                        <div class="textContent">
                                            <p>
                                                Indeed,
                                                <b
                                                    >we want our software to be extremely precise and to have sequences
                                                    that have been well characterized to specifically target certain
                                                    strains.</b
                                                >
                                                When designing our software, we considered the fact that currently, not
                                                all these specificity characteristics of bacteriophages have been
                                                characterized.
                                            </p>
                                            <p>
                                                That is why, <b>the software is open source</b> and is built to accept
                                                new data from researchers from all over the world who work on
                                                bacteriophages.
                                            </p>
                                            <!-- TOTO: Include software link -->
                                            <a x-data="{}" class="buttonLink" :href="'#'">Check Software</a>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isSafety">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="life-buoy" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Safety</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            We also had an informative conversation about environmental safety. Dr.
                                            Debarbieux incited us to pay additional attention to the environmental
                                            safety of our project by talking about modifying certain parts of our lab
                                            steps. As an example, to better designed plasmids that could not be
                                            transferred to other bacteria, we can make them untransferable by adding a
                                            blocker called ICEBs1. We could even consider to integrate the coding
                                            sequences we used directly in the bacterial genome.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>
                                            This strategy corresponds to phase 3: the self-destruction of our engineered
                                            bacteria via a kill switch
                                        </h3>
                                        <div class="textContent">
                                            <a x-data="{}" class="buttonLink" :href="window.ROOT_URL + '/Phases/phase3'"
                                                >Check phase 3</a
                                            >
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isPerspectives">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="rotate-ccw" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Perspectives</div>
                            </div>
                            <div class="mb-6">A type of personalized medicine</div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            According to him, if our project were to go further, our probiotic
                                            production would be patient-specific and not systemic like antibiotics.
                                        </p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <div id="government" class="mt-32">
            <div class="fixedIcon">
                <div class="fixedIconContent">
                    <img x-data="{}" :src="window.LINKS.humanPratices1.url" />
                    <div>
                        Government<br />
                        Agency
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="textContent bigText addPadding">
                    Regulatory affairs officers from government agencies are the people in charge of studying the drug’s
                    benefit to risk ratio.<br />
                    For the perspectives of our project, contacted people who could inform us on the end point of our
                    proof of concept.
                </div>
                <div class="profile mt-16">
                    <div class="profileLine"></div>
                    <div class="profileLeft">
                        <div class="profileImg">
                            <img x-data="{}" :src="window.LINKS.humanPratices10.url" />
                        </div>
                        <div class="profileName">Dr. Madec</div>
                        <div class="profileStatus">FRENCH AGENCY FOR FOOD, ENVIRONMENTAL AND HEALTH SAFETY</div>
                    </div>
                    <div class="profileRight">
                        <div class="profileQuote">"The key is to assure the specificity of your system"</div>
                        <div class="profileDescription">
                            Dr. Madec is the Research Director at the French Agency for Food, Environmental and Health
                            Safety (Anses). He is also the Scientific Director of the antimicrobial resistance topic and
                            the Head of the Research Unit “Antimicrobial Resistance and Virulence” at the Anses Lyon.
                            His research focuses on molecular genetics and epidemiology of AMR in Gram negative and
                            positive bacteria of animal origin and issues regarding the animal-to-human transfer of AMR
                            (and vice-versa). His expertise both in research and in regulation is very valuable for the
                            BacTail project.
                        </div>
                    </div>
                </div>
            </div>
            <div class="mt-16 emphaseContent">
                <div class="container">
                    <div class="addPadding">Dr. Madec finds our project promising.</div>
                </div>
            </div>
            <div class="container">
                <div class="issuesList mt-16">
                    <div class="issueCategory isStrategy">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="crosshair" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Strategy</div>
                            </div>
                            <div class="mb-6">Specificity is a must.</div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Dr. Madec really points out the fact that in order to assure that our system
                                            is well secure, we must be certain about the specificity of our conception.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>Digging deeper into investigating phage specificity</h3>
                                        <div class="textContent">
                                            <p>
                                                Through literature, we payed attention to
                                                <b>bacteriophage specificity to their host</b> in order to build our
                                                project and more precisely, conceive our software tool.
                                            </p>
                                            <p>
                                                We looked for annotated reads library in order to make sure that we have
                                                <b
                                                    >enough information on phages that could be used in the future for
                                                    BacTail.</b
                                                >
                                            </p>
                                            <a x-data="{}" class="buttonLink" :href="window.ROOT_URL + '/Phases/phase1'"
                                                >Check phase 1</a
                                            >
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isSafety">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="life-buoy" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Safety</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            The use of phages is strictly regulated, and this is limiting regarding a
                                            mass treatment. Our bacteria, thanks to synthetic biology, are controllable
                                            and cannot cause any harm to Humans, animals or the environment thanks to
                                            their genetic conception.
                                        </p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isSociety">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="globe" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Society</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Our biggest strength is to use therapeutic bacteria which, according to him
                                            would be less “scary” than phages that are viruses by nature.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>The term “virus” is worrying for society</h3>
                                        <div class="textContent">
                                            <p>
                                                The point brought up by Dr. Madec was very interesting for the
                                                <b>way we communicated</b> on our project to the general public.
                                            </p>
                                            <p>
                                                Indeed,
                                                <b
                                                    >the advantage is that BacTail doesn’t consist in using
                                                    bacteriophages,</b
                                                >
                                                which are known as viruses, but instead, it aims at harnessing their
                                                specific recognition abilities. This
                                                <b>specificity is the key element</b> of BacTail as it assures part of
                                                the safety.
                                            </p>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <div class="choiceView">
            <div class="container">
                <div class="textContent bigText addPadding">
                    During our crowdfunding in July, a student in last year of Veterinary School reached out to us with
                    a very motivating message :
                </div>

                <div class="profile mt-16">
                    <div class="profileLine"></div>
                    <div class="profileLeft">
                        <div class="profileImg">
                            <img x-data="{}" :src="window.LINKS.humanPratices24.url" />
                        </div>
                        <div class="profileName">Adèle Clément</div>
                    </div>
                    <div class="profileRight">
                        <div class="profileDescription">
                            "Your project is very concrete, and it could really make a difference. Veterinarians have a
                            lot of problems with antibiotic resistant bacteria and if we could administer your
                            engineered bacteria to our animals and save them it would be great!"
                        </div>
                    </div>
                </div>
                <div class="textContent addPadding mt-8">
                    Prior to this message, our team was mostly focusing on antimicrobial resistance and its effect on
                    human beings. It is at this moment, that we really realized that
                    <b>animals are equally as affected by AMR as humans.</b> Meaning, our final system could also be
                    administered in the case of bacterial infections in animals. We started to dig deeper into this
                    possibility and <b>talk with different stakeholders in the animal care sector.</b>
                </div>
                <div class="buttonList mt-8">
                    <button class="buttonElm" target-id="veterinarians">Veterinarian</button>
                    <button class="buttonElm" target-id="farmers">Farmers/Breeders</button>
                </div>
            </div>
        </div>

        <div id="veterinarians" class="mt-32">
            <div class="fixedIcon">
                <div class="fixedIconContent">
                    <img x-data="{}" :src="window.LINKS.humanPratices4.url" />
                    <div>Veterinarians</div>
                </div>
            </div>
            <div class="container">
                <div class="textContent bigText addPadding">
                    Veterinarians and farmers are also on the field, looking at how to fight AMR as this issue impacts
                    animals.<br />
                    Veterinary doctors also showed us the possible perspectives of our project.<br />
                    Getting insights from breeders helped us to understand the impact of this issue in this sector.
                </div>
                <div class="profile mt-16">
                    <div class="profileLine"></div>
                    <div class="profileLeft">
                        <div class="profileImg">
                            <img x-data="{}" :src="window.LINKS.humanPratices11.url" />
                        </div>
                        <div class="profileName">Dr. Chardon</div>
                        <div class="profileStatus">INTERBEV</div>
                    </div>
                    <div class="profileRight">
                        <div class="profileQuote">"BacTail is especially very interesting in extreme emergencies"</div>
                        <div class="profileDescription">
                            Dr. Chardon is a veterinary doctor invested in public health issues. She is currently the
                            Head of Research & Development at Interbev, a national interprofessional association of
                            cattle and meat. Her expertise is in fields such as health security, environment, animal
                            health, welfare and protection.
                        </div>
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="issuesList mt-16">
                    <div class="issueCategory isStrategy">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="crosshair" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Strategy</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            We have learnt many important details concerning a potential application on
                                            animals. For example, E. coli are abundant bacteria in farm animals. Dr.
                                            Chardon’s insights helped us shape our project mainly regarding our target
                                            strains. Indeed, depending on if the bacterial strains affect Humans or
                                            animals, the entire conception of our project (plasmid designs,
                                            pharmacokinetics, etc.…) would have to change.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>A tailor-made system using our software tool</h3>
                                        <div class="textContent">
                                            <p>
                                                We considered Dr. Chardon’s comment on the different strains that we
                                                would have to target for our software tool.
                                            </p>
                                            <p>
                                                Indeed,
                                                <b
                                                    >depending on the target strain, our software will be able to
                                                    determine the ideal BioBrick design to be inserted into our
                                                    plasmid.</b
                                                >
                                            </p>
                                            <p>
                                                Regarding the pharmacokinetics, they would also need to be tested for
                                                every characterized BrioBrick construct.
                                            </p>

                                            <!-- TOTO: Add soft link-->
                                            <a x-data="{}" class="buttonLink" :href="'#'">Check software</a>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isSociety">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="globe" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Awareness</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Despite a successful French plan called "eco-antibio" which was an awareness
                                            plan about the use of antibiotics in the context of livestock production, a
                                            plateau effect has been reached and some strains have become resistant.
                                        </p>
                                    </div>
                                </div>
                            </div>
                            <div class="issueSection mt-6">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Our team also had the opportunity to talk with Dr. Chardon about the
                                            public’s vision on biotechnology. She believes that having a great public
                                            engagement is the only way to raise social awareness on therapeutic
                                            bacteria. It is essential explain how our technology is safe thanks to
                                            strong knowledge in synthetic biology and insist on how it would be
                                            accessible to anyone.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>Public and Social Engagement</h3>
                                        <div class="textContent">
                                            <!-- TOTO: Add public engagement link-->
                                            <a x-data="{}" class="buttonLink" :href="'#'">Check public engagement</a>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isRegulation">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="list" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Regulation</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            We obtained great insight about regulation aspects. Currently we are only at
                                            the beginning of our project and if were to go to the end of its conception
                                            with a marketing authorization, it would take us a decade. However, because
                                            our project targets a global health issue, it could be used thanks to an
                                            “emergency use authorization” if our preliminary results seem convincing.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>Proposed implementation</h3>
                                        <div class="textContent">
                                            <p>
                                                These comments we useful for us when thinking about the
                                                <b
                                                    >future perspectives of our therapeutic bacteria and how they could
                                                    be used in society.</b
                                                >
                                            </p>
                                            <p>
                                                How are probiotics regulated? How about modified probiotics? What is the
                                                marketing authorization and how could it be applied to our project?
                                            </p>

                                            <!-- TOTO: Add proposed implementation link-->
                                            <a x-data="{}" class="buttonLink" :href="'#'"
                                                >Check proposed implementation</a
                                            >
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <div id="farmers" class="mt-32">
            <div class="fixedIcon">
                <div class="fixedIconContent">
                    <img x-data="{}" :src="window.LINKS.humanPratices4.url" />
                    <div>Farmers</div>
                </div>
            </div>
            <div class="container">
                <div class="textContent bigText addPadding">
                    All in all, we discussed our project with 7 different farmers, either by phone or directly meeting
                    up with them as you can see in the picture below. As all the talks were interesting, we decided to
                    present two which were the most inciteful.
                </div>
                <div class="profile mt-16">
                    <div class="profileLine"></div>
                    <div class="profileLeft">
                        <div class="profileImg">
                            <i data-feather="user" style="height: 80px; width: 80px"></i>
                        </div>
                        <div class="profileName">Mr. Brideron</div>
                    </div>
                    <div class="profileRight">
                        <div class="profileQuote">
                            "If an animal gets antibiotics, we must wait 45 days before they are cleared"
                        </div>
                        <div class="profileDescription">
                            Mr. Brideron is a cow and sheep breeder located in the Yonne department as well. He is
                            responsible for 350 sheep and 70 cows to produce raw materials like milk and meat.
                        </div>
                    </div>
                </div>
            </div>

            <div class="container">
                <div class="issuesList mt-16">
                    <div class="issueCategory isIssue">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="alert-circle" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Issues</div>
                            </div>
                            <div class="mb-6">How Mr. Brideron faces antibiotic resistance</div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Bacterial infections cause a lot of problems to his farm animals but also to
                                            him because it impacts his production. After an antibiotic injection, the
                                            animals cannot be slaughtered before 45 days, the average time before
                                            antibiotics are eliminated by them. In case of mastitis (mammal infection),
                                            his heard cannot produce milk anymore. Furthermore, it is becoming more and
                                            more difficult to get antibiotics which increase the risk for his animals’
                                            health. One of Mr. Brideron’s methods to avoid infections is to provide a
                                            surface of 12sqm per cow and a good diet.
                                        </p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="issueCategory isPerspectives">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="rotate-ccw" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">Perspectives</div>
                            </div>
                            <div class="mb-6">Appropriate diagnostic methods for animals are missing</div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Diagnostic, which is most of the time, only an auto diagnostic by checking
                                            the cow’s temperature is a problem Mr. Brideron mentions. He really hopes to
                                            find a fast and low-cost test kit to better diagnostic his herd.
                                            Furthermore, it is becoming more and more difficult to get antibiotics which
                                            increase the risk for his animals’ health.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>What if we use our therapeutic approach to create a diagnostic test?</h3>
                                        <div class="textContent">
                                            <p>
                                                How are bacterial infections currently being diagnosed? What are the
                                                weaknesses? How could we help? These are some questions that we could
                                                ask ourselves if we decided to
                                                <b>add diagnostics to our project goals as future perspectives.</b> Due
                                                to strict regulation, creating a diagnostic tool using our specificity
                                                system may be a more concrete perspective, instead of opting for
                                                therapeutics and administering bacteria animals.
                                            </p>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="container">
                <div class="profile mt-16">
                    <div class="profileLine"></div>
                    <div class="profileLeft">
                        <div class="profileImg">
                            <img x-data="{}" :src="window.LINKS.humanPratices12.url" />
                        </div>
                        <div class="profileName">Mr. Daviray and Thomas</div>
                    </div>
                    <div class="profileRight">
                        <div class="profileQuote">
                            "For now, antimicrobial resistance is not that frequent, but it is very worrying"
                        </div>
                        <div class="profileDescription">
                            Mr. Daviray is a breeder since 1990 located in the Yonne department. He is responsible for
                            around 110 milk producing cows.
                        </div>
                    </div>
                </div>
            </div>

            <div class="mt-16 emphaseContent">
                <div class="container">
                    <div class="addPadding">
                        Mr. Daviray congratulated us and thinks that there should be more innovative projects in the
                        animal production sector.
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="issuesList mt-16">
                    <div class="issueCategory isInfo">
                        <div class="issueCategoryLine"></div>
                        <div class="issueCategoryContent">
                            <div class="issueCategoryCategoryHeader">
                                <i data-feather="info" class="issueCategoryIcon"></i>
                                <div class="issueCategoryTag">General Information</div>
                            </div>
                            <div class="issueSection">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            We have learnt a lot on this economic sector, and we were delighted to see
                                            that French government’s campaigns on antimicrobial resistance have worked.
                                            Indeed, Mr. Daviray seems aware on this issue and confirmed that now the
                                            usage of antibiotics has really changed since last 30 years. Their purchase
                                            is organized thanks to an operating health report. Commonly, thanks to a
                                            global change of point of view, antibiotics are not used in a systemic
                                            manner.
                                        </p>
                                    </div>
                                </div>
                            </div>
                            <div class="issueImg mt-8">
                                <img x-data="{}" :src="window.LINKS.humanPratices13.url" />
                            </div>
                            <div class="issueSection mt-8">
                                <div class="issue">
                                    <div class="textContent">
                                        <p>
                                            Antibiotics are only used in cases of calving accidents, umbilical
                                            infections of calves and in cases of injury. Mr. Daviray has not really
                                            encountered antimicrobial resistance but is kind of worried because proven
                                            solutions have not been found yet.
                                        </p>
                                    </div>
                                </div>
                                <div class="resolve">
                                    <i data-feather="users" class="resolveIcon"></i>
                                    <div class="resolveAllContent">
                                        <h3>Animal healthcare is an interesting sector for our project</h3>
                                        <div class="textContent">
                                            <p>
                                                Both Mr. Brideron and Mr. Daviray were conscious about the
                                                <b
                                                    >antibiotic resistance issue potentially affecting their
                                                    livestock.</b
                                                >
                                                We learnt about the methods they apply to decrease the need of
                                                antibiotics for their animals as <b>economic losses</b> occur when an
                                                animal must take antibiotics (i.e. cannot produce milk anymore).
                                            </p>
                                            <p>
                                                Finally, they mentioned the
                                                <b>need for a better diagnostic method.</b> This last idea is something
                                                we could think about for future perspectives as our iGEM project is in
                                                therapeutics.
                                            </p>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="mt-16 emphaseContent">
                <div class="container">
                    <div class="addPadding">
                        For this year in iGEM, our team preferred to stay focused on the Human health application.<br />
                        However, thanks to these interviews, we have learnt on how our work may be useful to another
                        sector and we hope that some iGEM teams would be interested in developing some solutions against
                        antimicrobial resistance for animal health in the future.
                    </div>
                </div>
            </div>
        </div>
        <div id="philosophy" class="mt-32">
            <div class="fixedIcon">
                <div class="fixedIconContent">
                    <img x-data="{}" :src="window.LINKS.humanPratices2.url" />
                    <div>Philosophy</div>
                </div>
            </div>
            <div class="container">
                <div class="textContent bigText addPadding">
                    A long-term view of the impact our project could have on society and in the World
                </div>
                <div class="profile mt-16">
                    <div class="profileLine"></div>
                    <div class="profileLeft">
                        <div class="profileImg">
                            <img x-data="{}" :src="window.LINKS.humanPratices14.url" />
                        </div>
                        <div class="profileName">David Ricardo Galeano</div>
                        <div class="profileStatus">
                            Master student in Philosophy of Science, Knowledge and Mind, Sorbonne University (Paris)
                        </div>
                    </div>
                    <div class="profileRight">
                        <div class="profileQuote">
                            "Biology is a living concept while engineering is a mathematical tool"
                        </div>
                        <div class="profileDescription">
                            David Ricardo Galeano studied philosophy for 3 years at the Denominational Faculties of
                            Philosophy and Psychology (IPC), and is currently pursuing a specialization with a Masters
                            in Philosophy of Science, Knowledge and Mind at Sorbonne University.
                        </div>
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="issuesList mt-16">
                    <div class="issueSection">
                        <div class="issue">
                            <h3>Reflections on synthetic biology</h3>
                            <div class="textContent">
                                <p>
                                    After we presented our project, David Galeano explained to us that biology is a
                                    living concept while engineering science relies on purely mathematical tools.
                                </p>
                                <p>
                                    With our project, we seek an innovative solution combining biology with engineering
                                    sciences. So we are confident in saying that schematically, synthetic biology
                                    combines mathematical tools of engineering with the living concept of biology.
                                    <b
                                        >The main difficulty we face is that these mathematical tools seem to render
                                        conclusions necessary while the living component belongs to the domain of the
                                        contingent.</b
                                    >
                                </p>
                                <p>
                                    Our role as scientists is to be
                                    <b>conscious of the balance and order established in nature</b> so that, by working
                                    with it, we can unfold its full potential. Otherwise, we may be tempted to perform
                                    on living beings without trying to understand them.
                                </p>
                                <p>
                                    The work we undertake, with its experimental failures, is a great opportunity which
                                    demonstrates that
                                    <b
                                        >the living being is not a machine and that the primary measure will always be
                                        the living organism and not our hypotheses.</b
                                    >
                                </p>
                            </div>
                            <h3 class="mt-8">Reflections on the societal aspect</h3>
                            <div class="textContent">
                                <p>
                                    David Galeano also made us reflect on the
                                    <b>general impact of the release of new technology in our society.</b> As
                                    scientists, it is often
                                    <b>difficult to anticipate long-term social repercussions.</b>
                                </p>
                                <p>
                                    In our case, the BacTail project seeks to provide an innovative solution to
                                    antibiotic resistance. In the event that BacTail becomes accessible to all, we can
                                    expect both positive and negative impacts.
                                </p>
                                <p>
                                    Indeed, in many countries, antibiotics are seen as the only and most effective way
                                    to combat infections; people are rarely aware of the damage caused by such drugs.
                                </p>
                                <p>
                                    <b>The introduction of BacTail could prompt such awareness.</b> On the other hand,
                                    the project could cause
                                    <b
                                        >economic disruption in places where pharmacology is an important source of
                                        income.</b
                                    >
                                </p>
                                <p>
                                    However, talking about economic issues amounts to talking about social issues in our
                                    current society.
                                </p>
                            </div>
                        </div>
                        <div class="resolve">
                            <i data-feather="users" class="resolveIcon"></i>
                            <div class="resolveAllContent">
                                <h3>Are people willing to use our product?</h3>
                                <div class="textContent">
                                    <p>
                                        After speaking with David Galeano, we took a fresh look at our project and its
                                        purpose. More precisely, this discussion
                                        <b>prompted us to reflect on aspects outside our scientific field.</b> We
                                        decided to launch an online questionnaire to
                                        <b
                                            >assess people’s willingness to take, or not to take, our innovative
                                            solution to antibiotics.</b
                                        >
                                    </p>

                                    <!-- TOTO: Add survey link-->
                                    <a class="buttonLink" target-id="society">Check survey</a>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <div id="society" class="mt-32">
            <div class="fixedIcon">
                <div class="fixedIconContent">
                    <img x-data="{}" :src="window.LINKS.humanPratices6.url" />
                    <div>Society</div>
                </div>
            </div>
            <div class="emphaseContent mt-8">
                <div class="container">
                    <div class="">
                        <p>
                            As the main idea of our project is to administer our probiotic to human beings, we thought
                            it would be important to
                            <b>gather some input and a general opinion from the end users: society.</b>
                        </p>
                        <p>
                            In order to have a better understanding on how society views Genetically Modified Organisms,
                            especially in the context of our project, BacTail, we conducted a survey. Thanks to
                            intensive communication,
                            <b>we were able to reach 324 people from all over the Globe (19 countries).</b>
                        </p>
                    </div>
                </div>
            </div>
            <div class="stats">
                <div class="container">
                    <div class="textContent mt-16">
                        <h3>Population sample</h3>
                        <p>
                            From our form, we saw that nearly 70% of the responses come from a population aged between
                            <b>18-24</b> and <b>41-50 years old</b> (Fig. 1). 50,3% come from
                            <b>people who are not actively working in a science field</b> (Fig. 2) and 77,7% of
                            responses come from <b>France</b> (Fig. 3).
                        </p>
                    </div>
                    <div class="statsList">
                        <div class="statsItem">
                            <img x-data="{}" :src="window.LINKS.humanPratices15.url" />
                            <div class="statsLegend">Fig 1. Age distribution</div>
                        </div>
                        <div class="statsItem">
                            <img x-data="{}" :src="window.LINKS.humanPratices16.url" />
                            <div class="statsLegend">Fig 2. Field of expertise</div>
                        </div>
                        <div class="statsItem">
                            <img x-data="{}" :src="window.LINKS.humanPratices17.url" />
                            <div class="statsLegend">Fig 3. Countries reached by the form</div>
                        </div>
                    </div>
                    <div class="textContent mt-16">
                        <h3>Knowledge about bacteria and antibiotics</h3>
                        <p>
                            To make our analysis reliable, we first had to
                            <b>assess the population sample’s global knowledge about bacteria and antibiotics.</b>
                            Thanks to some questions, we saw that nearly 70% of them have a <b>clear idea</b> about what
                            bacteria are (Fig. 4), 95% know that bacteria are living organisms (Fig. 5). We were
                            surprised to see that 95% are
                            <b>conscious that bacteria are not necessarily pathogenic</b> for humans or animals (Fig.
                            6). Therefore, 82,7% know that we do not have to directly take antibiotics in case of a
                            bacterial infection, it should be prescribed by a practician (Fig. 7). 50% are convinced
                            that antibiotics are only effective against bacteria (Fig. 8).
                        </p>
                        <p>
                            Thanks to these questions, we saw that
                            <b
                                >a great proportion of the population sample has a good idea of what bacteria are and
                                their link to human health.</b
                            >
                            Still, we decided to continue our public engagement in order to raise more awareness on the
                            link between bacteria, human health, and antibiotic consumption. As well as the fact that
                            antibiotics are only effective against bacteria.
                        </p>
                    </div>
                    <div class="statsList">
                        <div class="statsItem">
                            <img x-data="{}" :src="window.LINKS.humanPratices18.url" />
                            <div class="statsLegend">Fig 4. Do you precisely know what bacteria are ?</div>
                        </div>
                        <div class="statsItem">
                            <img x-data="{}" :src="window.LINKS.humanPratices19.url" />
                            <div class="statsLegend">Fig 7. Field of expertise</div>
                        </div>
                    </div>
                    <div class="textContent mt-16">
                        <h3>Knowledge about antimicrobial resistance</h3>
                        <p>
                            BacTail aims at tackling antimicrobial resistance. We wanted to
                            <b>see if our population sample has been made aware of this global health issue.</b> Indeed,
                            94,1% know that bacteria can become resistant to antibiotics (Fig. 9). 63,6% are conscious
                            that one day, if a solution isn’t found, we will not be able to defend ourselves against
                            pathogenic bacteria (Fig. 10).
                        </p>
                        <p>
                            Because 77,7% of the responses come from France, this overall knowledge can be explain
                            thanks to <b>numerous governmental and social actions</b> conducted in order to raise
                            people’s awareness on bacteria and antimicrobial resistance.
                        </p>
                    </div>
                    <div class="statsList">
                        <div class="statsItem">
                            <img x-data="{}" :src="window.LINKS.humanPratices20.url" />
                            <div class="statsLegend">Fig 9. Antimicrobial resistance</div>
                        </div>
                        <div class="statsItem">
                            <img x-data="{}" :src="window.LINKS.humanPratices21.url" />
                            <div class="statsLegend">Fig 10. Antimicrobial resistance issue consciousness</div>
                        </div>
                    </div>
                    <div class="textContent mt-16">
                        <h3>Vision on our technology</h3>
                        <p>
                            Finally, we wanted gather insight on <b>people’s opinions</b> regarding our project. 63,6%
                            of them would be ready to take our therapeutic bacteria in case of infection (Fig. 11).
                            However, this number rises to 87% in case of an imminent death caused by a bacterial
                            infection (Fig. 12).
                        </p>
                        <p>
                            Out of 324 people, many seem to be willing to consume our therapeutic bacteria. People are
                            even <b>more willing when it is in the case of death</b> and as a last resort solution.
                        </p>
                    </div>
                    <div class="statsList">
                        <div class="statsItem">
                            <img x-data="{}" :src="window.LINKS.humanPratices22.url" />
                            <div class="statsLegend">Fig 11. Willing to use our technology</div>
                        </div>
                        <div class="statsItem">
                            <img x-data="{}" :src="window.LINKS.humanPratices23.url" />
                            <div class="statsLegend">Fig 12. Willing to use our technology in case of emergency</div>
                        </div>
                    </div>
                    <div class="textContent mt-16">
                        <p>
                            However, we must keep in mind that
                            <b>324 people is a small number to generalize the data</b> we have collected and transpose
                            it to the entire world, but the <b>statistics are very encouraging.</b> These results are
                            assuming our technology is totally safe for a market launch, which is not the case in the
                            context of our project and the iGEM Competition.
                        </p>
                    </div>
                </div>
            </div>
        </div>

        <div class="references">
            <div class="container">
                <hr />
                <div class="referencesText mb-6">
                    [1] Hutchings, M. I., Truman, A. W., & Wilkinson, B. (2019). Antibiotics: past, present and future.
                    Current Opinion in Microbiology, 51, 72–80. https://doi.org/10.1016/j.mib.2019.10.008<br />
                    [2] Alice Genyi, Market Analysis for Antibiotic Discovery and Development, Archives of clinical
                    microbiology, url:
                    https://www.acmicrob.com/microbiology/pmarket-analysis-for-antibiotic-discovery-and-developmentp.php?aid=24818<br />
                    [3] NA, New report calls for urgent action to avert antimicrobial resistance crisis, World Health
                    Organization, url:
                    https://www.who.int/news-room/detail/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis<br />
                    [4] NA, Antimicrobial resistance, World Economic Forum, url:
                    https://reports.weforum.org/global-risks-2018/anti-microbial-resistance/<br />
                    [5] Fair, R. J., & Tor, Y. (2014). Antibiotics and Bacterial Resistance in the 21st Century.
                    Perspectives in Medicinal Chemistry, 6, PMC.S14459. https://doi.org/10.4137/PMC.S1445A<br />
                    [6] NA, Biggest Threats and Data 2019 AR Threats Report, Centers for Disease Control and Prevention,
                    url: https://www.cdc.gov/drugresistance/biggest-threats.html<br />
                    [7] Grasso, G., Zane, D., & Dragone, R. (2020). Microbial nanotechnology: challenges and prospects
                    for green biocatalytic synthesis of nanoscale materials for sensoristic and biomedical
                    applications. Nanomaterials, 10(1), 11.<br />
                </div>
            </div>
        </div>

        <footer></footer>
    </body>
    <style>
        html,
        body {
            background-color: #fafafa !important;
        }

        /* Description */

        #description h1 {
            display: none;
        }

        #description {
            display: flex;
            flex-direction: column;
            justify-content: center;
            min-height: 80vh;
            background-repeat: no-repeat;
            background-position: top -80px right -80px;
            background-size: auto 100%;
        }

        .descriptionContent {
            width: 100%;
            display: flex;
            justify-content: flex-start;
            flex-wrap: wrap;
            gap: 20px;
        }

        .descriptionText {
            display: flex;
            flex-direction: column;
            align-items: flex-start;
            justify-content: center;
            text-transform: uppercase;
            font-weight: 800;
            line-height: 1;
        }

        @keyframes description2 {
            0% {
                position: relative;
                top: 200px;
                opacity: 0;
            }

            50% {
                position: relative;
                top: 200px;
                opacity: 0;
            }

            100% {
                position: relative;
                top: 0px;
            }
        }

        .descriptionText2 {
            color: #8d1f24;
            font-size: 50px;
            text-shadow: 0px 10px 20px rgba(141, 31, 37, 0.3);
            animation: description2 2s;
        }

        .descriptionText1 {
            color: #8d1f24;
            text-shadow: 0px 10px 20px rgba(251, 31, 29, 0.2);
            font-size: 50px;
            animation: description1 1s;
        }

        @keyframes descriptionLogo {
            0% {
                opacity: 0;
            }

            100% {
                opacity: 1;
            }
        }
        @keyframes description1 {
            0% {
                position: relative;
                left: 100px;
                opacity: 0;
            }

            100% {
                position: relative;
                left: 0px;
            }
        }

        /* ALL */

        .punchline {
            color: #8d1f24;
            font-size: 25px;
            font-weight: 800;
            text-align: center;
        }

        h2 {
            color: #8d1f24;
            background-color: rgba(141, 31, 37, 0.1);
            padding: 10px 20px;
            line-height: 1;
            border-radius: 10px;
            display: inline-block;
            font-size: 25px;
            font-weight: 800;
        }

        .arrowRightPrevious {
            display: inline-flex;
            align-items: center;
            font-weight: 800;
            gap: 20px;
            background-color: rgba(0, 0, 0, 0.05);
            border-radius: 30px 99px 99px 30px;
            padding: 10px 20px;
        }

        .textContent {
            max-width: 900px;
            font-size: 15px;
        }

        .addPadding {
            padding: 0 20px;
        }

        .emphaseContent {
            background-color: rgba(141, 31, 37, 0.05);
            padding: 50px 0;
        }

        .timelineMult {
            display: flex;
            align-items: center;
            justify-content: center;
        }

        .timelineMultItem {
            flex-shrink: 0;
            max-width: 200px;
            flex-grow: 1;
        }

        .timelineMultItemTag {
            color: #8d1f24;
            background-color: rgba(141, 31, 37, 0.1);
            display: inline-block;
            padding: 2px 5px;
            font-size: 12px;
            font-weight: 800;
            text-transform: uppercase;
            border-radius: 5px;
            margin-bottom: 10px;
        }

        .timelineMultItemMiddle {
            display: flex;
            flex-direction: column;
            align-items: center;
            margin: 0 40px;
        }

        .timelineMultItemArrow {
            height: 60px;
            width: 60px;
        }

        .timelineMultItemMult {
            font-size: 40px;
            font-weight: 800;
            color: #8d1f24;
            line-height: 1;
        }

        .arrowRightNextContainer {
            display: flex;
            justify-content: flex-end;
        }

        .arrowRightNext {
            display: flex;
            align-items: center;
            font-weight: 800;
            gap: 20px;
            background-color: rgba(0, 0, 0, 0.05);
            border-radius: 99px 30px 30px 99px;
            padding: 10px 20px;
        }

        .iconBig {
            height: 60px;
            width: 60px;
            color: #8d1f24;
        }

        /* LIST CLICK */

        .listClic {
            display: flex;
            justify-content: center;
            align-items: stretch;
            flex-wrap: wrap;
            gap: 20px;
        }

        .listClicItem {
            background-color: white;
            border-radius: 5px;
            display: flex;
            flex-shrink: 0;
            align-items: stretch;
            overflow: hidden;
            -webkit-box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            -moz-box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            height: 150px;
            max-width: 500px;
            flex-grow: 1;
            transform: scale(1);
            transition: transform 0.3s;
            cursor: pointer;
        }

        .listClicItem:hover {
            transform: scale(1.05);
            position: relative;
            z-index: 5;
        }

        .listClicItemLeft {
            display: flex;
            flex-direction: column;
            text-align: center;
            align-items: center;
            justify-content: center;
            background-color: #8d1f24;
            color: white;
            flex-grow: 1;
            max-width: 130px;
            min-width: 130px;
            flex-shrink: 0;
        }

        .listClicItemLeftContainer {
            display: flex;
            flex-direction: column;
            align-items: center;
        }

        .listClicItemLeftIcon > img {
            max-height: 50px;
            max-width: 50px;
            width: 100%;
            height: 100%;
        }

        .listClicItemLeftText {
            margin-top: 10px;
        }

        .listClicItemRight {
            padding: 10px;
            display: flex;
            align-items: center;
            border-left: 1px solid rgba(0, 0, 0, 0.05);
        }

        .fixedIcon {
            position: sticky;
            top: 20px;
            left: 0px;
            width: 100%;
            display: flex;
            justify-content: flex-end;
        }

        .fixedIconContent {
            background-color: #8d1f24;
            box-shadow: 0px 10px 20px rgba(141, 31, 37, 0.1);
            padding: 20px 20px;
            border-radius: 10px 0 0 10px;
            display: flex;
            flex-direction: column;
            align-items: center;
            color: white;
            font-size: 14px;
        }

        .fixedIconContent > div {
            margin-top: 10px;
            text-align: center;
        }

        .fixedIconContent > img {
            max-width: 70px;
            max-height: 70px;
            width: 100%;
        }

        .bigText {
            font-size: 20px;
        }

        .profile {
            display: inline-flex;
            background-color: white;
            -webkit-box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            -moz-box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            border-radius: 10px;
            align-items: stretch;
            overflow: hidden;
        }

        .profileLeft {
            flex-shrink: 0;
            width: 200px;
            padding: 0 0 30px 0;
            display: flex;
            flex-direction: column;
            align-items: center;
            text-align: center;
        }

        .profileImg {
            overflow: hidden;
            border-radius: 999px;
            margin: 50px 0 0 0;
        }

        .profileImg > img {
            object-fit: cover;
            height: 120px;
            width: 120px;
        }

        .profileName {
            font-size: 15px;
            font-weight: 800;
            margin: 20px 10px 0 10px;
        }

        .profileStatus {
            font-size: 15px;
            margin: 5px 0 0 0;
        }

        .profileRight {
            margin: 30px 30px 30px 0;
            display: flex;
            flex-direction: column;
        }

        .profileLine {
            width: 8px;
            background-color: #8d1f24;
            flex-shrink: 0;
        }

        .profileQuote {
            max-width: 900px;
            font-size: 30px;
            font-weight: 800;
            line-height: 1.2;
            color: #8d1f24;
            font-style: italic;
        }

        .profileDescription {
            margin: 20px 0 0 0;
            font-style: 15px;
            max-width: 900px;
        }

        .subProfile {
            display: flex;
            align-items: center;
        }

        .subProfileIcon {
            height: 40px;
            width: 40px;
            margin-right: 30px;
        }

        /* ISSUES */

        .issueSection {
            display: flex;
            flex-direction: column;
            align-items: stretch;
            max-width: 1000px;
        }

        .issueSection h3 {
            color: #8d1f24;
            font-size: 20px;
        }

        .issue > div {
            margin-top: 10px;
        }

        .issue {
            background-color: white;
            border-radius: 10px;
            padding: 40px 30px;
            border: 1px solid rgb(241, 241, 241);

            -webkit-box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            -moz-box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
        }

        .resolve {
            margin: 0 20px;
            background-color: rgba(0, 0, 0, 0.02);
            border-radius: 0 0 10px 10px;
            display: flex;
            border: 1px solid rgb(241, 241, 241);
        }

        .resolveIcon {
            flex-shrink: 0;
            margin: 20px;
            height: 40px;
            width: 40px;
            color: #8d1f24;
        }

        .resolveAllContent {
            padding: 20px 20px 20px 0;
        }

        .resolveAllContent > div {
            margin-top: 20px;
        }

        .textContent p {
            margin-bottom: 5px;
        }

        .textContent p:last-child {
            margin-bottom: 0;
        }

        .buttonLink {
            background-color: rgba(0, 0, 0, 0.02);
            border-radius: 5px;
            display: inline-block;
            padding: 10px 20px;
            border: 1px solid rgba(0, 0, 0, 0.03);
            cursor: pointer;
            color: black;
            text-decoration: none;
            margin-top: 20px;
        }

        .buttonLink:hover {
            background-color: rgba(0, 0, 0, 0.05);
            color: black;
            text-decoration: none;
        }

        .issueCategory {
            display: flex;
            align-items: stretch;
            margin-bottom: 40px;
        }

        .issueCategoryLine {
            flex-shrink: 0;
            width: 4px;
            border-radius: 99px;
            margin-right: 20px;
        }

        .issueCategoryCategoryHeader {
            display: flex;
            align-items: center;
        }

        .issueCategoryIcon {
            height: 30px;
            width: 30px;
        }

        .issueCategoryTag {
            text-transform: uppercase;
            font-size: 17px;
            font-weight: 800;
            margin-left: 20px;
            padding: 5px 20px;
            border-radius: 5px;
        }

        .issueCategoryCategoryHeader {
            margin-bottom: 20px;
        }

        .issueImg > img {
            max-height: 300px;
            max-width: 300px;
            overflow: hidden;
            border-radius: 10px;
        }

        /* STRATEGY COLORS */
        .isStrategy .issueCategoryLine {
            background-color: rgb(85, 0, 150);
        }

        .isStrategy .issueCategoryCategoryHeader,
        .isStrategy .resolveIcon,
        .isStrategy h3 {
            color: rgb(85, 0, 150);
        }

        .isStrategy .issueCategoryTag {
            background-color: rgba(85, 0, 150, 0.1);
        }

        /* SAFETY COLORS */
        .isSafety .issueCategoryLine {
            background-color: rgb(0, 150, 115);
        }

        .isSafety .issueCategoryCategoryHeader,
        .isSafety .resolveIcon,
        .isSafety h3 {
            color: rgb(0, 150, 115);
        }

        .isSafety .issueCategoryTag {
            background-color: rgba(0, 150, 115, 0.1);
        }

        /* PERSPECTIVES COLORS */
        .isPerspectives .issueCategoryLine {
            background-color: rgb(0, 95, 162);
        }

        .isPerspectives .issueCategoryCategoryHeader,
        .isPerspectives .resolveIcon,
        .isPerspectives h3 {
            color: rgb(0, 95, 162);
        }

        .isPerspectives .issueCategoryTag {
            background-color: rgba(0, 94, 162, 0.1);
        }

        /* SOFTWARE COLORS */
        .isSoftware .issueCategoryLine {
            background-color: rgb(168, 64, 0);
        }

        .isSoftware .issueCategoryCategoryHeader,
        .isSoftware .resolveIcon,
        .isSoftware h3 {
            color: rgb(168, 64, 0);
        }

        .isSoftware .issueCategoryTag {
            background-color: rgba(168, 64, 0, 0.1);
        }

        /* SOCIETY COLORS */
        .isSociety .issueCategoryLine {
            background-color: rgb(168, 0, 62);
        }

        .isSociety .issueCategoryCategoryHeader,
        .isSociety .resolveIcon,
        .isSociety h3 {
            color: rgb(168, 0, 62);
        }

        .isSociety .issueCategoryTag {
            background-color: rgba(168, 0, 62, 0.1);
        }

        /* REGULATION COLORS */
        .isRegulation .issueCategoryLine {
            background-color: rgb(176, 0, 0);
        }

        .isRegulation .issueCategoryCategoryHeader,
        .isRegulation .resolveIcon,
        .isRegulation h3 {
            color: rgb(176, 0, 0);
        }

        .isRegulation .issueCategoryTag {
            background-color: rgba(176, 0, 0, 0.1);
        }

        /* INFO COLORS */
        .isInfo .issueCategoryLine {
            background-color: rgb(86, 86, 86);
        }

        .isInfo .issueCategoryCategoryHeader,
        .isInfo .resolveIcon,
        .isInfo h3 {
            color: rgb(86, 86, 86);
        }

        .isInfo .issueCategoryTag {
            background-color: rgba(149, 149, 149, 0.1);
        }

        /* ISSUE COLORS */
        .isIssue .issueCategoryLine {
            background-color: #8d1f24;
        }

        .isIssue .issueCategoryCategoryHeader,
        .isIssue .resolveIcon,
        .isIssue h3 {
            color: #8d1f24;
        }

        .isIssue .issueCategoryTag {
            background-color: rgba(141, 31, 37, 0.1);
        }

        /* STATS */

        .stats h3 {
            color: #8d1f24;
            font-size: 20px;
            margin-bottom: 10px;
        }

        .statsList {
            display: flex;
            flex-wrap: wrap;
            justify-content: center;
            gap: 20px;
            margin-top: 80px;
        }

        .statsItem {
            text-align: center;
            display: flex;
            flex-direction: column;
            align-items: center;
        }

        .statsItem > img {
            max-width: 500px;
            max-height: 400px;
            border-radius: 20px;
        }

        .statsLegend {
            margin-top: 5px;
            font-size: 15px;
            font-style: italic;
        }

        /* REFERENCE */
        .references {
            margin-top: 60px;
        }

        .referencesText {
            margin-top: 10px;
            font-size: 13px;
            color: rgba(0, 0, 0, 0.6);
        }

        /* Veterinarian / Farmers/Breeders */

        .choiceView {
            margin: 120px 0;
        }

        .buttonList {
            display: flex;
            justify-content: center;
            align-items: center;
        }

        .buttonElm {
            background-color: rgba(0, 0, 0, 0.02);
            border-radius: 5px;
            padding: 10px 20px;
            border: 1px solid rgba(0, 0, 0, 0.03);
            cursor: pointer;
            max-width: 200px;
            flex-grow: 1;
        }

        .buttonElm:hover {
            background-color: rgba(0, 0, 0, 0.05);
        }

        .buttonElm:first-child {
            margin-right: 30px;
        }
    </style>
</html>
